BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

506 related articles for article (PubMed ID: 19828674)

  • 1. Epidemiology of Chlamydia trachomatis infection in women and the cost-effectiveness of screening.
    Land JA; Van Bergen JE; Morré SA; Postma MJ
    Hum Reprod Update; 2010; 16(2):189-204. PubMed ID: 19828674
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Overestimation of complication rates in evaluations of Chlamydia trachomatis screening programmes--implications for cost-effectiveness analyses.
    van Valkengoed IG; Morré SA; van den Brule AJ; Meijer CJ; Bouter LM; Boeke AJ
    Int J Epidemiol; 2004 Apr; 33(2):416-25. PubMed ID: 15082651
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preventing infective sequelae of abortion.
    Penney GC
    Hum Reprod; 1997 Nov; 12(11 Suppl):107-12. PubMed ID: 9433966
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk of sequelae after Chlamydia trachomatis genital infection in women.
    Haggerty CL; Gottlieb SL; Taylor BD; Low N; Xu F; Ness RB
    J Infect Dis; 2010 Jun; 201 Suppl 2():S134-55. PubMed ID: 20470050
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Opportunistic screening for genital infections with Chlamydia trachomatis in sexually active population of Amsterdam. II. Cost-effectiveness analysis of screening women].
    Postma MJ; Welte R; van den Hoek JA; van Doornum GJ; Coutinho RA; Jager JC
    Ned Tijdschr Geneeskd; 1999 Mar; 143(13):677-81. PubMed ID: 10321301
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chlamydia trachomatis infection in women with secondary infertility.
    Malik A; Jain S; Rizvi M; Shukla I; Hakim S
    Fertil Steril; 2009 Jan; 91(1):91-5. PubMed ID: 18635168
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chlamydia trachomatis infection in fertile and subfertile women in Rwanda: prevalence and diagnostic significance of IgG and IgA antibodies testing.
    Muvunyi CM; Dhont N; Verhelst R; Temmerman M; Claeys G; Padalko E
    Hum Reprod; 2011 Dec; 26(12):3319-26. PubMed ID: 22016415
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Chlamydia infections and tubal infertility].
    Vegheş S; Lupaşcu I; Solomiţchi V; Duca E; Fochi M
    Rev Med Chir Soc Med Nat Iasi; 2004; 108(3):617-23. PubMed ID: 15832986
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Productivity losses attributable to untreated chlamydial infection and associated pelvic inflammatory disease in reproductive-aged women.
    Blandford JM; Gift TL
    Sex Transm Dis; 2006 Oct; 33(10 Suppl):S117-21. PubMed ID: 17003678
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chlamydia trachomatis infection of the female genital tract. Pathogenetic and clinicopathologic correlations.
    Winkler B; Crum CP
    Pathol Annu; 1987; 22 Pt 1():193-223. PubMed ID: 3554120
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enzyme immunoassay in the diagnosis of Chlamydia trachomatis infections in diverse patient groups.
    Bakir TM; Hossain A; De-Silva S; Siddiqui A; Sengupta BS; el-Sheikh MM; Bakir AF
    J Hyg Epidemiol Microbiol Immunol; 1989; 33(2):189-97. PubMed ID: 2671155
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Chlamydia antibody testing for tubal factor subfertility].
    Lardenoije CM; Land JA
    Ned Tijdschr Geneeskd; 2007 Sep; 151(36):1981-5. PubMed ID: 17953171
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The cost and cost-effectiveness of opportunistic screening for Chlamydia trachomatis in Ireland.
    Gillespie P; O'Neill C; Adams E; Turner K; O'Donovan D; Brugha R; Vaughan D; O'Connell E; Cormican M; Balfe M; Coleman C; Fitzgerald M; Fleming C
    Sex Transm Infect; 2012 Apr; 88(3):222-8. PubMed ID: 22213681
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chlamydia trachomatis infection as a risk factor for infertility among women in Ghana, West Africa.
    Siemer J; Theile O; Larbi Y; Fasching PA; Danso KA; Kreienberg R; Essig A
    Am J Trop Med Hyg; 2008 Feb; 78(2):323-7. PubMed ID: 18256439
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of the laboratory in a Chlamydia control programme in a developing country.
    Peeling RW; Oyelese AO; Brunham RC; Achola JO; Ronald AR
    East Afr Med J; 1992 Sep; 69(9):508-14. PubMed ID: 1286634
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The program cost and cost-effectiveness of screening men for Chlamydia to prevent pelvic inflammatory disease in women.
    Gift TL; Gaydos CA; Kent CK; Marrazzo JM; Rietmeijer CA; Schillinger JA; Dunne EF
    Sex Transm Dis; 2008 Nov; 35(11 Suppl):S66-75. PubMed ID: 18830137
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Incidence of genital Chlamydia trachomatis infection in the male partners attending an infertility clinic.
    Arya R; Mannion PT; Woodcock K; Haddad NG
    J Obstet Gynaecol; 2005 May; 25(4):364-7. PubMed ID: 16091321
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tubal factor pathology caused by Chlamydia trachomatis: the role of serology.
    Mouton JW; Peeters MF; van Rijssort-Vos JH; Verkooyen RP
    Int J STD AIDS; 2002 Dec; 13 Suppl 2():26-9. PubMed ID: 12537722
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chlamydia trachomatis: impact on human reproduction.
    Paavonen J; Eggert-Kruse W
    Hum Reprod Update; 1999; 5(5):433-47. PubMed ID: 10582782
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Screening for asymptomatic Chlamydia trachomatis infection in pregnancy; cost-effectiveness favorable at a minimum prevalence rate of 3% or more].
    Postma MJ; Bakker A; Welte R; van Bergen JE; van den Hoek JA; de Jong-van den Berg LT; Jager JC
    Ned Tijdschr Geneeskd; 2000 Dec; 144(49):2350-4. PubMed ID: 11129971
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.